ApoC-II mimetic peptides could also possibly be beneficial in some metabolic diseases, such as in diabetes, in which delivery of TG by lipoproteins to peripheral tissues is known to be impaired [38]. This evidence concerns the gene APOC2 and diabetes mellitus.